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ABSTRACT
Deoxycytidine kinase (dCK) is a rate limiting enzyme
critical for phosphorylation of endogenous deoxy-
nucleosides for DNA synthesis and exogenous nu-
cleoside analogues for anticancer and antiviral drug
actions. dCK is activated in response to DNA
damage; however, how it functions in the DNA
damage response is largely unknown. Here, we
report that dCK is required for the G2/M checkpoint
in response to DNA damage induced by ionizing
radiation (IR). We demonstrate that the ataxia–
telangiectasia-mutated (ATM) kinase phosphoryl-
ates dCK on Serine 74 to activate it in response to
DNA damage. We further demonstrate that Serine 74
phosphorylation is required for initiation of the G2/M
checkpoint. Using mass spectrometry, we identified
a protein complex associated with dCK in response
to DNA damage. We demonstrate that dCK interacts
with cyclin-dependent kinase 1 (Cdk1) after IR and
that the interaction inhibits Cdk1 activity both
in vitro and in vivo. Together, our results highlight
the novel function of dCK and provide molecular
insights into the G2/M checkpoint regulation in
response to DNA damage.
INTRODUCTION
As the human genome is constantly challenged by envir-
onmental DNA damaging agents, cells have developed
comprehensive control systems to deal with these insults
in order to maintain genome stability and promote
survival. Among the protective mechanisms, cell cycle
checkpoints exist to halt cell cycle progression at the
G1/S border (the G1 checkpoint), throughout the
S-phase (the intra-S checkpoint) or at the G2/M border
(the G2/M checkpoint) (1). The overall function of cell
cycle checkpoints is to provide time for the cell to
process DNA repair before division and to determine
whether programmed cell death is necessary should the
damage be beyond repair. Cell cycle checkpoints are
regulated by signaling cascades involving evolutionally
conserved proteins that include damage sensors, signal
transducers, mediators and effectors (2). For example,
the Mre11-Rad50-Nbs1 (MRN) complex acts as a sensor
to recruit the ataxia–telangiectasia-mutated (ATM) kinase
in the event of DNA double strand breaks (3). It is well
documented that the ATM kinase is a central element
critical for signal amplification to facilitate cell cycle
checkpoints (4). Indeed, ATM belongs to a conserved
protein kinase family related to phosphatidylinositol 3
kinase-like kinases. ATM phosphorylation of downstream
targets is essential to initiate cell cycle checkpoints (5).
Critical understanding of the cell cycle checkpoint regula-
tory network relies on elucidating the crosstalk between
DNA damage response pathways and cell cycle regulators.
Since cell cycle progression is driven by cyclin-dependent
kinases (Cdks) (6), Cdks are prime targets of DNA
damage response proteins for initiation of cell cycle
arrest. Among them, Cdk1, encoded by the CDC2 gene,
functions as a critical Cdk for the G2/M transition and
mitosis (7). Mediated by Wee1, Cdk1 is inhibited by
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phosphorylation at a conserved tyrosine 15 residue (8,9).
This inhibition can be counteracted by Cdc25 phosphatase
family members (10). ATM-mediated Chk2 phosphoryl-
ation/activation antagonizes the function of Cdc25 phos-
phatases, thereby indirectly inhibiting Cdk1 activity and
leading to activation of the G2/M checkpoint (11). Besides
these functions, Cdk1 is also involved in a feedback loop
with PLK1, 53BP1 and Chk2 which serves to inactivate
the G2/M DNA damage checkpoint (12).
Deoxycytidine kinase (dCK) is a critical enzyme respon-
sible for phosphorylation of 20-deoxycytidine, 20-deoxy-
adenosine and 20-deoxyguanosine to their corresponding
monophosphorylated forms (13). This reaction is the first
and rate limiting step in deoxyribonucleoside salvage,
which provides deoxynucleoside triphosphates for DNA
replication and repair. dCK is also critical for activation
of a number of anticancer and antiviral nucleoside ana-
logues, such as fludarabine, cladribine, gemcitabine,
clofarabine, zalcitabine and lamivudine (14). Due to its
broad role in DNA synthesis and drug action, dCK has
been suspected of playing a role in the cellular response to
DNA damage, though a detailed mechanism has yet to be
described. dCK activity is enhanced in response to treat-
ment with IR, UV and genotoxic drugs such as
aphidicolin, etoposide and certain nucleoside analogues
(15,16). Post-translational modification, especially phos-
phorylation, of dCK is critical for its enzymatic activity.
Among several potential phosphorylation sites, Serine 74
has emerged as the most critical site for activated dCK
(17). The kinases responsible for in vivo dCK Serine 74
phosphorylation are largely unknown; although Casein
kinase 1 d (CK1 d) has been reported to phosphorylate
dCK on Serine 74 in vitro (18).
Given that dCK is activated in response to DNA
damage and plays a critical role in DNA synthesis, we
hypothesized that dCK is essential for optimal DNA
damage responses. Here we report that ATM phosphor-
ylation of dCK on Serine 74 is essential to activate the G2/
M checkpoint in response to DNA damage. We have
identified a complex that associates with dCK in
response to DNA damage and we demonstrate that
dCK interacts with and inactivates Cdk1 to initiate the
G2/M checkpoint.
MATERIALS AND METHODS
Cell culture
Human cervical carcinoma cell line HeLa and human em-
bryonic kidney cell line HEK293T (The American Type
Culture Collection, Manassas, VA, USA) were grown in
Dulbecco’s modified Eagle’s medium (DMEM; Gibco,
Carlsbad, CA, USA) supplemented with 10% fetal
bovine serum and 50 mg/ml of penicillin/streptomycin
(Thermo Fisher, Waltham, MA, USA) at 37C under
5% CO2 and a 95% relative humidity atmosphere. The
isogenic cell lines stably expressing ATM and control
shRNA were maintained in DMEM supplemented with
1 mg/ml puromycin as described previously. EBV-trans-
formed lymphoblast GM0536 (ATM+/+) and GM1526
(ATM/) cells (The NIGMS Human Mutant Cell
Repository, Camden, NJ, USA) were maintained in
Roswell Park Memorial Institute (RPMI) 1640 medium
(Thermo Fisher, Waltham, MA, USA) supplemented
with 10% fetal bovine serum and 50 mg/ml of penicillin/
streptomycin.
Construction of dCK knockdown stable cell lines
Stable cell lines with knockdown of dCK were generated
according to a vector-based knockdown strategy. SiRNA
target sites (siRI: 436-454 and siRII: 148-166) were
designed according to siRNA Target Finder (http://
www.ambion.com/techlib/misc/siRNA_finder.html).
ShRNA was subcloned into the pHTsiRNA vector at
BglII and XhoI sites. HeLa cell lines were transfected
with the pHT-dCK-siRNA vector and empty vector
using Effectene Transfection Reagent (Qiagen, Valencia,
CA, USA) and cells were cultured under puromycin
(4 mg/ml) selection. Puromycin-resistant colonies were in-
dividually picked up and detected by RT–PCR and
western blotting. Stable cell clones were maintained in
DMEM supplemented with 1 mg/ml Puromycin.
Plasmids
Full-length coding sequences of dCK were amplified by
RT–PCR and subcloned into the vector pcDNA3. The
dCK-S74A, dCK-S74E mutants and siRNA-resistant
dCK-WT, S74A and S74E plasmids were generated
using the QuikChange II XL site-directed Mutagenesis
Kit (Stratagene, La Jolla, CA, USA) according to the
manufacturer’s protocol. The primers used are shown in
the following table.
Antibodies
Anti-ATM, anti-CDK1-Y15p and anti-beta actin
antibodies were purchased from Abcam Inc (Cambridge,
MA, USA). Anti-dCK was obtained from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Anti-Cdk1 was
purchased from Millipore (Billerica, MA, USA). The
rabbit dCK–Ser74p antibody, generated as described pre-
viously (17).
Western blotting
Whole-cell lysates were extracted, quantified and sub-
jected to electrophoresis with Criterion 4–12% precast
XT Bis-Tris gels (Bio-Rad, Hercules, CA, USA) in
Primer’s name Sequences
dCK-WT-F 50-tcactagtatggccaccccgcccaagagaagc-30
dCK-WT-R 50-acgctcgatcacaaagatctcaaaaactctt-30
dCK-S74A-F 50-cttacaatggcacagaaaaatggtgg-30
dCK-S74A-R 50-ccaccatttttctgtgccattgtaag-30
dCK-S74E-F 50-cttacaatggaacagaaaaatggtgg-30
dCK-S74E-R 50-ccaccatttttctgttccattgtaag-30
dCK-siRI-Res-F 50-gaagattgggaagtcgtcccagagccagtcgccagatg-30
dCK-siRI-Res-R 50-catctggcgactggctctgggacgacttcccaatcttc-30
dCK-siRII-Res-F 50-gtatgaatctgaatgtatgaacgaaactgaatggacaat-30
dCK-siRII-Res-R 50-attgtccattcagtttcgttcatacattcagattcatac-30
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XT MOPS Running Buffer (Bio-Rad), and subsequently
transferred to nitrocellulose membranes (Pall Life
Sciences, Ann Arbor, MI, USA). Membranes were
then blocked with 5% non-fat dry milk solution
(Lab Scientific, Inc., Livingston, NJ, USA) at room
temperature for 1 h, incubated with primary antibodies
overnight, secondary antibodies at room temperature for
1 h, and visualized with the Pierce chemiluminescence
detection system (Thermo Scientific Pierce, Rockford,
IL, USA).
Immunoprecipitation followed by mass spectrometry
Whole-cell lysates were incubated with Anti-FLAG-M2
Agarose beads (Sigma, St Louis, MO, USA) overnight
at 4C. The samples were then washed three times with
500 ml TBS buffer, eluted in 40 ml Laemmli buffer and
placed in a boiling water bath for 5min. The eluted
proteins were analyzed on an SDS–PAGE gel followed
by silver staining. The bands which showed different
patterns among dCK-WT and S74A treated with/
without IR were processed for identification using mass
spectrometry (Synapt HDMS; Waters Corporation,
Milford, MA. USA).
In vitro kinase assay
For the Cdk1 in vitro kinase assay, recombinant dCK
(Novus Biologicals, Littleton, CO, USA) and Cdk1/
CyclinA2 (Promega, Madison, WI, USA) were incubated
with 1 mg of Histone H1 (Promega) in the presence of
50 mM ATP in kinase buffer for 30min at room tempera-
ture. Cdk1 inhibitor CAS220749-41-7 (Santa Cruz
Biotechnology) was used as a positive control. The
kinase activity of Cdk1 was measured by quantifying the
amount of ADP produced using the ADP-GLOTM kinase
assay (Promega). Briefly, 5 ml of ADP-GLOTM reagent
were incubated with the reaction products at room tem-
perature for 40min. Luminescence was recorded after
incubation with 10 ml of the kinase detection reagent for
30min at room temperature.
The ATM in vitro kinase assay was performed accord-
ing to the method described previously (19), using the
dCK- Ser74p antibody.
dCK activity assay
dCK activity in GM0536 and GM1526 cells was
determined by measuring and comparing the activation
of Ara-C to Ara-CTP using an assay described by
Parker et al. (20). Briefly, acid-soluble extracts were
obtained after cells were incubated with 100 mM Ara-C
for 30min. Intracellular nucleotides were eluted from a
Nucleosil SB silica SAX column (Interchim, Montlucon,
France) with a 30min linear gradient from 7 to 500mM
KH2PO4 (pH 4.0), followed by 20min of 500mM
KH2PO
4 (pH 4.0) at a flow rate of 2ml/min.
Intracellular nucleotides including Ara-CTP were
detected by UV absorbance at 260 nm.
Irradiation
Cells were irradiated at various doses using an XRAD 320
X-ray irradiator (Precision X-Ray, Inc., CT, USA) at a
dose rate of 75 cGy/min at room temperature.
Clonogenic survival assay
Cells were seeded into 6-well plates in triplicate and then
incubated for 24 h to allow settling. Cells were treated with
Ara-C (0–1mM) for 24 h or irradiated (0–6Gy). After 7–10
days, the culture dishes were stained with 0.5% crystal
violet and the number of colonies (more than 50 cells)
was counted.
G2/M checkpoint assay
A total of 70% ethanol-fixed cells were permeabilized with
0.25% Triton X-100 in PBS on ice for 5min. Cell pellets
were blocked in PBS containing 1% bovine serum
albumin (BSA) for 30min followed by incubation with
the primary antibody (anti-phospho-Histone H3-Ser10)
(1: 200) (Millipore) at room temperature for 3 h and
with the secondary antibody (goat anti-rabbit
IgG-FITC) (1:200) (Santa Cruz Biotechnology) in the
dark for 30min. Cells were stained with 25 mg/ml
propidium iodide (Life Technology, Grand Island, NY,
USA) and the percentage of mitotic cells was quantified
by flow cytometry (BD FACS LSRII, CA, USA), as pre-
viously described (21).
RESULTS
dCK is involved in the optimal DNA damage response
To study the function of dCK in the DNA damage
response, we generated isogenic HeLa cell lines in which
control shRNA or dCK shRNA was stably expressed.
After confirming successful knock-down (Figure 1A), we
conducted a cytotoxicity assay using cytarabine (Ara-C), a
nucleoside analogue that requires dCK for drug action
(14). We found that cells with depleted dCK showed sig-
nificant resistance to Ara-C at lower doses (Figure 1B).
However, at higher doses of Ara-C treatment, the resist-
ance became less significant. To assess this dose response
discrepancy, we hypothesized that the resistant phenotype
of dCK knock-down to Ara-C could have been partially
reversed by hypersensitivity of the cells to DNA damage
induced by higher doses of Ara-C. Indeed, colony forma-
tion assays indicated that dCK knock-down cells dis-
played hypersensitivity in response to DNA damage
induced by ionizing radiation (IR) (Figure 1C), indicating
that dCK is required for the DNA damage response.
We further characterized the DNA damage response of
dCK knock-down cells by measuring the mitotic index. In
response to IR, we found that dCK knock-down cells,
unlike control cells, did not show a dramatic reduction
in the percentage of mitotic cells, indicating a defective
G2/M checkpoint (Figure 1D). A time course experiment
showed that dCK knock-down cells displayed significant
defects in the IR-induced G2/M checkpoint within the first
8 h following IR (Supplementary Figure S1).
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ATM is required for dCK activation in response to IR
dCK is activated in response to DNA damage induced
by IR, UV and chemotherapeutic drugs (15,16). As dCK
activation in response to DNA damage might play a
critical role in the DNA damage response, we intended
to investigate regulators of dCK activation. We
measured dCK activity in a pair of lymphoblastoid cells
lines in which ATM is either proficient (GM0536) or de-
ficient (GM1526). We observed that GM0536 cells showed
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Figure 1. dCK is required for the G2/M checkpoint in response to ionizing radiation. (A) Establishment of isogenic cell lines with stable dCK
knock-down. HeLa cells were stably transfected with control or dCK shRNA. Individual clones were obtained under puromycin selection.
Knock-down effects were confirmed by RT–PCR (left panel) and western blot (right panel). (B) The isogenic cell lines with control or dCK
knock-down were treated with Ara-C at indicated doses for 24 h, and clonogenic survival was assessed. (C) Radiosensitivity was assessed by the
colony formation assay in the isogenic cell lines after radiation treatment (0–6Gy). (D) Isogenic HeLa cells were treated with mock or IR treatment
(6Gy). Two hours after treatment, cells were harvested and fixed followed by staining for Histone H3 Ser10 phosphorylation for flow cytometry. The
average and standard deviations of at least triplicate samples are shown. Statistic analysis was done by Student’s t-test.
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dCK activation in response to IR, but GM1526 cells failed
to do so (Figure 2A). Interestingly, stably transfected
HeLa cells with shRNA against ATM (22) were signifi-
cantly resistant to Ara-C treatment (Figure 2B).
ATM is required for dCK Serine 74 phosphorylation both
in vitro and in vivo
To further study ATM-mediated dCK activation, we
hypothesized that ATM might phosphorylate dCK.
Among four potential in vivo phosphorylation sites
(Threonine 3, Serine 11, Serine 15 and Serine 74) (17),
Serine 74 fit into the SQ motif of the ATM consensus
sequence (23). Using a polyclonal antibody for dCK
Serine 74 phosphorylation, we first checked dCK Serine
74 phosphorylation in GM0536 and GM1526 cells. As
shown in Figure 2C, we observed a weak Serine 74 phos-
phorylation signal in the absence of DNA damage in
GM0536 cells. In cells treated with IR, a significant
increase in Serine 74 phosphorylation was observed. In
contrast, GM1526 cells displayed diminished dCK Serine
74 phosphorylation in the absence or presence of
IR-induced DNA damage. We also utilized the isogenic
HeLa cells lines with stably transfected control or ATM
shRNA to measure dCK Serine 74 phosphorylation.
Similarly, we observed that in ATM shRNA transfected
cells, IR-induced dCK Serine 74 phosphorylation is
defective (Figure 2D, left panel). These results indicate
that ATM is required for dCK Serine 74 phosphorylation.
It is noted that the phospho-Serine 74 antibody did not
recognize any signal in dCK shRNA knock down cells
(Figure 2D, right panel). To study whether dCK is
directly phosphorylated by ATM, we conducted an
in vitro kinase assay using a GST-ATM C-terminal
fragment as kinase and dCK peptides containing Serine
74 as substrate followed by western blot using the
anti-phospho-Serine 74 dCK antibody. As shown in
Figure 2E, we found that dCK Serine 74 is directly
phosphorylated by ATM in vitro. Together, these results
strongly indicate ATM phosphorylates dCK on Serine 74.
Additionally, during our initial study of ATM-mediated
dCK phosphorylation, dCK was reported to be among the
proteins phosphorylated by ATM in a large scale prote-
omic study (24).
ATM-mediated dCK Serine 74 phosphorylation is required
for the G2/M checkpoint
To study the functional significance of ATM-mediated
dCK phosphorylation, we transfected either vector only,
wild-type, serine 74 to alanine substitution (which abro-
gates phosphorylation) or the serine 74 to glutamic acid
substitution (which mimics phosphorylation) form of
dCK into dCK knock-down cells (Figure 3A). We then
conducted the G2/M checkpoint assay to assess whether
the serine to alanine mutation (S74A) would have an effect
on activation of the checkpoint. We found that wild-type
dCK rescued the G2/M checkpoint defect in dCK
knock-down cells (Figure 3B), further demonstrating the
essential role of dCK in the checkpoint. Interestingly,
unlike wild-type, the S74A mutant dCK was not capable
of restoring the checkpoint. Notably, unlike other
previously reported serine to alanine mutants of ATM
target proteins (21,25–27), S74A dCK does not possess a
dominant negative activity since over-expression of S74A
did not affect G2/M checkpoint activation in the
control shRNA cells. Note the level of dCK
overexpression compared to the endogenous dCK is
shown in Figure 3C.To further study the role of
ATM-mediated dCK Serine 74 phosphorylation, we
introduced the various dCK constructs into the isogenic
HeLa cell lines stably transfected with control or ATM
shRNA. We found that neither wild-type nor S74A dCK
was able to restore the G2/M checkpoint defect in ATM
knock-down cells. However, phospho-mimicking dCK
(S74E) complemented the G2/M checkpoint defect
(Figure 3D). These results strongly support the conclusion
that ATM-mediated dCK Serine 74 phosphorylation is
required for the activation of the IR-induced G2/M
checkpoint.
We also conducted the colony formation assay in dCK
shRNA knock-down cells expressing either vector only,
dCK WT, S74A or S74E. We found that similar to
dCK-WT, either S74A or S74E can rescue the radiosen-
sitivity phenotype of dCK knock-down cells (Supplemen-
tary Figure S2), indicating that ATM-mediated dCK
phosphorylation is not required for the maintenance of
radioresistance and that dCK-mediated G2/M checkpoint
regulation is independent of IR-induced radiosensitivity.
Identification of a dCK complex in
response to DNA damage
To further study the functional significance of dCK Serine
74 phosphorylation in the DNA damage response, we
aimed to identify a potential dCK complex that is
associated with DNA damage-induced phosphorylation.
To achieve this goal, we transfected flag-tagged
wild-type or the S74A mutant dCK into HeLa cells and
immunoprecipitated the exogenous dCK using an anti-flag
antibody. By mass spectrometry we identified a list of
proteins that specifically bind to wild-type but not S74A
dCK in response to IR (Supplementary Figure S3).
Noticeably, among the identified proteins, there are two
associated with cell cycle progression: Cdk1 and
Prohibitin 2.
ATM-mediated Serine 74 phosphorylation is required for
dCK and Cdk1 interaction
Given that ATM-mediated dCK phosphorylation is essen-
tial for activation of the G2/M checkpoint and that Cdk1
is an essential protein driving the G2/M transition, we
focused on the potential interaction of dCK and Cdk1
(Figure 4A). First, we validated the interaction of dCK
and Cdk1 in vivo. We transfected flag-tagged wild-type
or S74A dCK into HeLa cells and immunprecipitated ex-
ogenous dCK. We observed that Cdk1 associated with
dCK even in unperturbed cells (Figure 4B), including a
slight binding to the S74A form. In cells treated with
IR, the interaction was significantly increased as more
Cdk1 was brought down by wild-type dCK. More inter-
estingly, the S74A mutant dCK failed to
coimmunoprecipitate with Cdk1 (Figure 4B). We also
Nucleic Acids Research, 2012, Vol. 40, No. 19 9625
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/40/19/9621/2414694 by pam
ela.herring@
ucf.edu user on 04 M
arch 2019
conducted a reciprocal experiment by immunopre-
cipitation of Serine 74 phosphorylated dCK and looked
for Cdk1 interaction. Similarly, we found that Cdk1 only
interacted with the Serine 74 phosphorylated form of
dCK (Figure 4C). Furthermore, we found that in
ATM-deficient cells, the dCK-Cdk1 interaction in the
absence or presence of IR was significantly impaired
(Figure 4D). Together, these results indicate that the
dCK-Cdk1 interaction is enhanced in response to DNA
damage and that ATM-mediated dCK Serine 74 phos-
phorylation is required for the interaction.
dCK interaction with Cdk1 inhibits Cdk1
activity in vitro and in vivo.
To study the functional role of the interaction of dCK
with Cdk1, we conducted an in vitro kinase assay using
the recombinant Cdk1/Cyclin A2 as kinase and Histone
H1 as substrate. We found a dose-dependent inhibition
of Cdk1 activity by recombinant dCK (Figure 5A).
The inhibitory effect of dCK at the dose of 10 mg is
similar to that of a known Cdk1 inhibitor CAS220749-
41-7 (28). Because the inhibitory effect of dCK
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Figure 2. ATM phosphorylates dCK on Serine 74 in response to IR. (A) Lymphoblast cell lines GM0536 (ATM+/+) and GM1526 (ATM/) were
treated with mock or IR treatment (6Gy) followed by the dCK kinase assay as described in the methods. (B) Isogenic HeLa cells treated with
indicated doses of Ara-C for 24 h were assessed for colony formation ability. Survival fractions are shown. (C) EBV-transformed lymphoblast cells
lines, GM0536 and GM1526, were treated with mock or IR (6Gy). 2 h after radiation, whole cell lysates were harvested and subjected to immuno-
blotting using indicated antibodies. (D) HeLa cells stably transfected with control or ATM shRNA were treated with mock or IR (6Gy). Two hours
after radiation, whole-cell lysates were harvested and subjected for immunoblot using indicated antibodies. (E) The in vitro kinase assay was
performed using ATM fragments (either GST-tagged N-terminal amino acids 248–522 or C-terminal fragments of ATM amino acids 2709–2964)
in the presence of peptides containing the non-phosphorylated form of dCK (FEELTMSQKNGGNVL). The gel was immunoblotted with anti-dCK
Ser74p antibody. The phosphor-dCK peptide (FEELTMSpQKNGGNVL) was loaded as a positive control.
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Figure 3. ATM-mediated dCK Serine 74 phosphorylation is required for the IR-induced G2/M checkpoint. (A) dCK knock-down HeLa cells were
re-introduced with vector control, dCK wild-type, dCK Serine 74 to alanine (S74A) mutation or Serine 74 to Glutamic Acid (S74E) mutation. The
complementation effects using RT–PCR and western blot are shown. (B) The dCK complemented cell lines were treated with mock or IR (6Gy).
Two hours after treatment, cells were harvested and stained for Histone H3 Ser10 phosphorylation followed by flow cytometry. (C) Expression of
flag-tagged dCK as compared to endogenous dCK in control shRNA and ATM shRNA cells. (D) HeLa cells with control or ATM shRNA were
transiently transfected with vector, wild-type (WT), S74A or S74E of dCK and treated with IR (6Gy). Two hours after treatment, cells were
harvested and stained for Histone H3 Ser10 phosphorylation followed by flow cytometry analysis. The average and standard deviations of at least
triplicate samples are shown. Statistic analysis was done by Student’s t-test; *P 0.05.
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might not be solely dependent on interaction, we do not
rule out non-specific inhibition of dCK on Cdk1 in this
assay.
To study the in vivo effect of the dCK–Cdk1 interaction,
we investigated Cdk1 Tyrosine 15 phosphorylation, a
marker representing inhibition of Cdk1 activity. We
found that IR-induced Tyrosine 15 phosphorylation is sig-
nificantly impaired in dCK knock-down cells (Figure 5B).
Furthermore, reintroduction of wild-type or S74E dCK
significantly enhanced Tyrosine 15 phosphorylation in
response to IR in dCK knock-down cells (Figure 5C).
On the contrary, the S74A mutant dCK showed
significantly lowered Tyrosine 15 phosphorylation as
compared to that in vector cells. Taken together, our
results demonstrate that dCK interaction with Cdk1
directly inhibits Cdk1 activity, resulting in activation of
the G2/M checkpoint. It is noted that unlike Cdk1
Y15p, Chk2 Threonine 68 phosphorylation was not
affected by dCK S74A mutation.
DISCUSSION
Our study presented here highlights a critical, mechanistic
link between a DNA damage response signaling cascade
A
B
C IR D
IP: dCK-S74p
IB: dCK
IB: Cdk1
IB: Flag
IP: dCK
IB: Cdk1
IB: dCK
IgG    Ctrl shRNA       ATM shRNA
IR                  - +               - +
Input Input IB: ATMIB: dCK
IB: Cdk1
Figure 4. dCK interacts with Cdk1 in response to IR. (A) Mass spectrometry identified Cdk1 as one of the dCK association proteins. (B) Vector
control, flag-tagged wild-type or S74A dCK were transiently transfected into HeLa cells. After 36 h of transfection, the cells were treated with mock
or IR (6Gy). Two hours after IR, cells were harvested and subjected to immunoprecipitation using an anti-Flag antibody. The immunoprecipitates
were then blotted with indicated antibodies. (C) dCK knock-down HeLa cells were transfected with vector control, flag-tagged dCK-WT or
dCK-S74A and irradiated (6Gy). Two hours after IR, cells were harvested and immunoprecipitated with the anti-dCK Ser74p antibody. The
immunoprecipitates were then blotted with indicated antibodies. (D) Isogenic HeLa cells stably expressing control or ATM shRNA were treated
with mock or IR (6Gy). Two hours after IR, cells were harvested and endogenous dCK was immunoprecipitated followed by immunoblotting with
the indicated antibodies.
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(i.e. the ATM-dCK pathway) and the cell cycle regulator
Cdk1. While DNA damage-induced cell cycle checkpoints
have been extensively studied, many unsolved puzzles in
terms of critical links between DNA damage response
pathways and essential cell cycle activators still remain.
Cdk1, in complex with its cyclin partners, governs the
mitotic entry (7). Previous studies have demonstrated
that Cdk1 activation involves Tyrosine 15 dephosphory-
lation, which is partly governed by Cdc25A. Chk1 and
Chk2 phosphorylate Cdc25A and Cdc25C, leading to
Cdc25A ubiquitination and proteasomal degradation
and Cdc25C nuclear exclusion/cytoplasmic sequestration
via binding to 14-3-3 proteins (29). Our data presented in
this manuscript demonstrate that dCK functions as a
critical regulator of the G2/M checkpoint by interaction
and inhibition of Cdk1 activity upon DNA damage.
Though it is still not known to which dCK domains
Cdk1 binds to, it is likely that Serine 74 phosphorylation
leads to a conformational change that opens the accessi-
bility of dCK to Cdk1 or that enhances the affinity of
existing binding in unperturbed cells. The increased inter-
action of dCK and Cdk1 further inhibits Cdc25 phosphat-
ase dependent dephosphorylation of Tyrosine 15.
We demonstrate that dCK is a downstream kinase
regulated by ATM in the DNA damage response. dCK
is among as many as 700 proteins phosphorylated by
ATM in the DNA damage response (24). The functional
significance of ATM-mediated dCK phosphorylation is
demonstrated in this study.
The identification of the dCK complex reveals a more
comprehensive picture of the functional role of dCK in the
DNA damage response. In the dCK complex, there are a
number of interesting interacting proteins worthy of
further investigation. For example, the involvement of
Elongation Factor 1 (EEF-1) delta, which is essential for
the enzymatic delivery of aminoacyl tRNAs to the
ribosome (30), might indicate a cytosolic function of
dCK in response to DNA damage. Since EEF-1 is also a
substrate of Cdk1 (31), the complex containing dCK,
EEF-1 and Cdk1 might balance cell cycle regulation in
the presence of DNA damage. In addition, prohibitin 2,
also shown in the dCK complex after DNA damage, is
involved in various cellular functions such as cell cycle,
apoptosis, mitochondrial enzyme assembly, nuclear
receptor signaling and senescence (32,33–35). Interaction
with prohibitin 2 indicates broader functions of dCK in
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Figure 5. The dCK–Cdk1 interaction inhibits Cdk1 activity both in vitro and in vivo. (A) Cdk1 kinase activity was measured by an in vitro kinase
assay using the recombinant Cdk1/CyclinA2 complex incubated with 1 mg of Histone H1 as substrate in the presence of 50 mM ATP. Recombinant
dCKs at indicated doses were added into the kinase reaction, and the luminescence signal indicative of Cdk1 activity was recorded. The average and
standard deviations of at least triplicate samples are shown. (B) Isogenic HeLa cell lines with control or dCK shRNA were treated with mock or IR
(6Gy). Two hours after IR, total cell lysates were obtained and subjected to western blot analysis using indicated antibodies. (C) HeLa cells
transiently transfected with vector, flag-tagged wild-type, S74A or S74E were irradiated (6Gy). Total cell lysates were obtained and subjected to
western blot with indicated antibodies.
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cellular processes and stress responses. The complex might
also shed light on cellular phenotypes such as prolonged
G2/M accumulation in cells lacking dCK (unpublished
data). Since prolonged G2 accumulation results from a
lack of the intra-S-phase checkpoint (36), this potential
link might indicate that dCK also participates in the
intra-S-phase checkpoint in response to DNA damage.
The significance of these findings extends beyond mo-
lecular insights into cell cycle checkpoint regulation. Since
dCK activity is required for many chemotherapeutic drugs
for toxicity, the mechanism of dCK activation can be po-
tentially explored to optimize chemo-radiation combin-
ation therapy. This is supported by findings that many
nucleoside analogues display synergistic effects when
combined with radiation therapy (14). Many earlier
studies have suggested that nucleoside analogues can
inhibit DNA repair to serve as radiosensitizers (37).
While this is still a valid conclusion, our study indicates
a different mechanism for the synergistic effect as IR can
activate dCK through ATM and promote chemosen-
sitization. These observations might have a significant
impact in optimization of the treatment schedule for com-
bination treatment in the clinical setting.
In summary, our data demonstrated that dCK is
activated by ATM-mediated Serine 74 phosphorylation
in response to DNA damage and is required for the G2/
M checkpoint. Further, we demonstrated that dCK inter-
acts with and inhibits Cdk1 to activate the G2/M
checkpoint.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Figures 1–3.
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